Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate
Links shared publicly online about this topic.
- 400total visits
Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate
No abstract available
View full resource at content.karger.com
Tags: Multiple Sclerosis Medication, Copaxone, Tysabri
Most Recently Shared on March 31, 2011 at 4:03 am By:
Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and G... http://bit.ly/hT9bUe
Advertisement
